The strain, which is the newest addition to the company’s human health probiotics portfolio, achieved a “clinically meaningful response” for improving gut health for people with adults with IBS-D.
Danish enzyme and cultures suppliers Novozymes and Chr. Hansen plan to merge their businesses in a move they say will create a ‘leading global biosolutions partner’.
The Danish ingredients supplier is celebrating a ‘solid’ financial performance for 2021/22, despite a ‘volatile’ macroeconomic and geopolitical climate. We ask CFO Lise Mortensen how the Ukraine-Russia conflict is impacting business.
Chr. Hansen has received regulatory approval to supply a range of Human Milk Oligosaccharides (HMO) to new and existing global markets, following recent endorsements from Australia and New Zealand last year.
Christian Hansen has received EU safety approval for genetically modified (GM) 3-fucosyllactose (3-FL) oligosaccharide for infant formula (IF) and follow-on formula (FOF).
Every child has a different upbringing and is brought into the world with unique circumstances, but one thing their parents have in common is the wish to give their babies the best possible start.
The pace of consumer familiarity and confidence with probiotics is outlined in a new Chr. Hansen survey, which the firm suggests are opportunities for the global food industry to capitalise on.
Bacthera, the joint venture between Chr. Hansen and Lonza, is to team up with Seres Therapeutics to manufacture Seres’ lead product candidate for recurrent Clostridioides difficile infection (rCDI).
Chr. Hansen has received European Commission (EC) approval to produce a novel prebiotic used in infant formula from a new microbial source, in an application that further drives the products’ premiumisation.
Chr. Hansen has launched a probiotic-focused digital resource in response to heightened interest in microorganisms’ role in promoting general health, specifically supporting immune and respiratory health.
Chr. Hansen and Nestlé have settled a legal dispute involving alleged infringements on Human Milk Oligosaccharide (HMO) patents arising from October 2020’s acquisition of Jennewein Biotechnologie.
Chr. Hansen has highlighted the possible benefits probiotic supplements may have to shift workers, as a new study suggests they may offer support to the immune system and improvements to sleep quality.
Chr. Hansen is to acquire Jennewein Biotechnologie for €310m in a deal designed to merge the bioscience firm’s probiotic interests with the gains Jennewein have made in the Human Milk Oligosaccharides (HMO) market.
Denmark’s Chr. Hansen Holding A/S has today entered into an agreement with the owners of Wisconsin-based UAS Laboratories LLC to acquire 100% of the B2B probiotics company.
Chr. Hansen continues its strategy of populating its microbial platform with ‘bolt-on’ acquisitions with the addition of HSO Health Care, a company specialising in probiotics for women’s health.
Chr. Hansen has sealed a deal to supply probiotic ingredients to Teijin Limited, a Japanese prebiotic firm, for use in functional and health food applications in its domestic market.
Bacthera, the joint venture between Chr. Hansen and Lonza looking into Live Biotherapeutic Products (LBP), announces Lukas Schüpbach as the company’s new CEO.
Chr. Hansen makes available a new three-strain probiotic blend that the Danish bioscience company says can help halve the risk of Necrotising Enterocolitis (NEC) in premature babies.
Bacteria normally found in babies’ gut can prevent or even heal ulcers triggered by aspirin, according to European researchers, who think it could be added to patient diets as a natural supplement.
We talked to Chr Hansen CEO about selling dairy cultures to the biggest cheese makers in the US, how to double profitability in colours by 'ditching complexities' and why he is sceptical of (but still investing in) plant-based ingredients.
Chr Hansen has developed cultures for lacto-fermented soy and coconut yoghurts with the taste, texture and healthiness of traditional dairy. ‘It’s still niche but we want to be the first innovators here,” the firm says.
Probiotic and natural colours player Chr Hansen reported a 10% growth in organic revenue in the first nine months, leading the company to slightly raise full year expectations.
The €73m acquisition of a library of 3,200 probiotic strains will open up opportunities in children’s immune health, Chr Hansen’s CEO says as the firm posts 13% profit growth from last year.
'The race is on in this industry to take positions for future growth of probiotics.'
Danish probiotics and enzymes leader Chr Hansen has paid €73m in cash to acquire the Lactobacillus rhamnosus-based LGG suite of probiotic strains from Finnish dairy group, Valio.
Chr Hansen has reported ‘very satisfactory’ overall growth of 10%, as stronger performances in cultures, enzymes, and nutrition balance out below per performance in natural colours.
The world’s biggest clinical study on the immune effects of probiotics has found that the L. casei 431 strain could reduce the duration of symptoms from the common cold and flu – though no differences were found in the incidence or severity of illness.
Chr Hansen has confirmed the presence of bifidobacteria and lactobacilli in breast milk from Chinese mothers - a discovery it claims strengthens the case for adding probiotics to infant formula.
NutraIngredients is pleased to announce the shortlisted finalists for the inaugural NutraIngredients Awards, with the winners announced at our exclusive awards evening in Geneva on 6th May. Will you be joining us?
Danish probiotics player Chr Hansen has launched a patent-pending soft gel that can deliver live probiotics with a two-year shelf life and matched it with a probiotic-omega-3 supplement targeting pregnant women.
Danish ingredients giant Chr Hansen has today rebranded itself ‘Nature’s Number 1’ as it announced a 6-platform strategic overhaul of its colours, enzymes and cultures businesses.
German pharma giant Merck and global probiotics leader Chr Hansen have pulled the probiotic-allergy health claim they jointly submitted to the European Food Safety Authority (EFSA) less than four months ago.
Danish probiotics leader Chr Hansen, which ditched a €4m immunity trial for some of its probiotic strains last year, is participating in a new trial to determine if probiotics can reduce the number of infections in small children.
After 20 failed starts, probiotics leader Chr Hansen says it has finally found an ingredient dispensing cap partner that can handle the demands of high speed filling utilised by the world’s biggest beverage manufacturers.
Chr Hansen has commissioned a 1000-person+ trial seeking to demonstrate the immunity benefits of one of its flagship strains, Lactobacillus casei, as the leading Danish probiotics supplier continues to fight for Europe’s first approved probiotic health...
Intra-regional finesse is a necessity not a luxury when it comes to doing business in the many markets of the Asia-Pacific, as leading suppliers Chr Hansen and Danisco relayed at the recent Vitafoods Asia trade show in Hong Kong.
Danish probiotics giant Chr Hansen says its just-announced alliance with a Japanese botanical supplement maker will yield plant-probiotic combination food supplement products on European and global markets kicking off in Q1 2012.
Chr Hansen is anticipating a negative opinion on its 13.1 health claim submission for its BB12 probiotic this week, due to lack guidance from EFSA when it was made, and plans to re-submit under 13.5.
Chr Hansen has teamed up with Vietnamese dairy giant Vinamilk to develop bio science-based nutritional products for children – with the first product, containing BB-12 and LLG cultures due for launch.
Danish supplier Chr Hansen says the two probiotic-strain combination it has been promoting for more than a year to target women’s vaginal problems is now present in products in more than 20 countries, including India.
The private equity owner of Chr Hansen, PAI Partners, is evaluating the possibility of publically listing the company, the Danish ingredients company has confirmed.
